MedSci参加第三届亚太地区男科学论坛

2009-10-12 MedSci MedSci原创

10月10日,“第三届亚太地区男科学论坛(3APFA)暨《亚洲男科学杂志》创刊十周年庆”在南京国际会展中心召开。此次会议由中国科学院上海药物研究所、上海交通大学、南京医科大学主办,《亚洲男科学杂志》编辑部、南京医科大学生殖医学实验室承办,国际男科学会、中国科学院、中华医学会生殖医学分会等协办。此次论坛的主题是“环境、生活方式、遗传/表观遗传与男性健康”。 MedSci应邀参加了此次大会,MedSc

10月10日,“第三届亚太地区男科学论坛(3APFA)暨《亚洲男科学杂志》创刊十周年庆”在南京国际会展中心召开。此次会议由中国科学院上海药物研究所、上海交通大学、南京医科大学主办,《亚洲男科学杂志》编辑部、南京医科大学生殖医学实验室承办,国际男科学会、中国科学院、中华医学会生殖医学分会等协办。此次论坛的主题是“环境、生活方式、遗传/表观遗传与男性健康”。 MedSci应邀参加了此次大会,MedSci编辑李欣梅博士在大会学前培训班上作题为《From Idea To Paper》的精彩讲座。

此次大会特邀顾问有澳大利亚,澳大利亚莫纳什大学生殖与发育研究所教授,澳大利亚维多利亚州州长David de Kretser教授(澳大利亚)

中国科学院上海生命科学院,中国科学院院士张永莲;澳大利亚,澳大利亚ANZAC 研究所主任,国际男科学会前秘书长David J Handelsman教授 (澳大利亚)等。会上,国内外相关领域内同道齐聚一堂,共同探讨影响男性健康的复杂多样的诸因素,并制订改善与促进男性健康的发展战略。

MedSci编辑李欣梅博士在大会学前培训班上讲授了有关“课题设计”及“SCI论文写作和投稿”方面的知识,获得与会代表的热烈反响! MedSci有幸参与此次盛会,并与予会专家,学者进行了广泛而深入地交流,许多专家对MedSci的服务给予高度评价和支持,我们也一如既往保持高质量的编辑风格,坚持“选择我们,脱颖而出”的服务宗旨,为我们的作者提供优质,高效的服务。

PPT下载:From Idea To Paper

 

MedSci市场专员Jennifer与亚洲男科杂志王一飞主编合影

 

MedSci在大会上关于sci论文相关经验介绍的培训

 

Jennifer与外籍专家的合影

MedSci相关动态:

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=37388, encodeId=f9843e388ac, content=Big help, big help. And surevlatipe news of course., beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=adeline, createdTime=Sun Sep 27 07:30:00 CST 2015, time=2015-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687516, encodeId=70db168e5163e, content=<a href='/topic/show?id=0ea224245e4' target=_blank style='color:#2F92EE;'>#亚太#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24245, encryptionId=0ea224245e4, topicName=亚太)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ef428388125, createdName=ms2536978994064944, createdTime=Mon Jul 12 19:47:00 CST 2010, time=2010-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=687, encodeId=fd3768e76, content=办的不错~, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=weiwei, createdTime=Wed Oct 14 15:27:00 CST 2009, time=2009-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543322, encodeId=5ad21543322d0, content=<a href='/topic/show?id=0dc224246b2' target=_blank style='color:#2F92EE;'>#亚太地区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24246, encryptionId=0dc224246b2, topicName=亚太地区)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=539b13566968, createdName=ms5439512287675881, createdTime=Wed Oct 14 04:47:00 CST 2009, time=2009-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605508, encodeId=33961605508d9, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Wed Oct 14 04:47:00 CST 2009, time=2009-10-14, status=1, ipAttribution=)]
    2015-09-27 adeline

    Big help, big help. And surevlatipe news of course.

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=37388, encodeId=f9843e388ac, content=Big help, big help. And surevlatipe news of course., beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=adeline, createdTime=Sun Sep 27 07:30:00 CST 2015, time=2015-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687516, encodeId=70db168e5163e, content=<a href='/topic/show?id=0ea224245e4' target=_blank style='color:#2F92EE;'>#亚太#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24245, encryptionId=0ea224245e4, topicName=亚太)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ef428388125, createdName=ms2536978994064944, createdTime=Mon Jul 12 19:47:00 CST 2010, time=2010-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=687, encodeId=fd3768e76, content=办的不错~, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=weiwei, createdTime=Wed Oct 14 15:27:00 CST 2009, time=2009-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543322, encodeId=5ad21543322d0, content=<a href='/topic/show?id=0dc224246b2' target=_blank style='color:#2F92EE;'>#亚太地区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24246, encryptionId=0dc224246b2, topicName=亚太地区)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=539b13566968, createdName=ms5439512287675881, createdTime=Wed Oct 14 04:47:00 CST 2009, time=2009-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605508, encodeId=33961605508d9, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Wed Oct 14 04:47:00 CST 2009, time=2009-10-14, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=37388, encodeId=f9843e388ac, content=Big help, big help. And surevlatipe news of course., beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=adeline, createdTime=Sun Sep 27 07:30:00 CST 2015, time=2015-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687516, encodeId=70db168e5163e, content=<a href='/topic/show?id=0ea224245e4' target=_blank style='color:#2F92EE;'>#亚太#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24245, encryptionId=0ea224245e4, topicName=亚太)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ef428388125, createdName=ms2536978994064944, createdTime=Mon Jul 12 19:47:00 CST 2010, time=2010-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=687, encodeId=fd3768e76, content=办的不错~, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=weiwei, createdTime=Wed Oct 14 15:27:00 CST 2009, time=2009-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543322, encodeId=5ad21543322d0, content=<a href='/topic/show?id=0dc224246b2' target=_blank style='color:#2F92EE;'>#亚太地区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24246, encryptionId=0dc224246b2, topicName=亚太地区)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=539b13566968, createdName=ms5439512287675881, createdTime=Wed Oct 14 04:47:00 CST 2009, time=2009-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605508, encodeId=33961605508d9, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Wed Oct 14 04:47:00 CST 2009, time=2009-10-14, status=1, ipAttribution=)]
    2009-10-14 weiwei

    办的不错~

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=37388, encodeId=f9843e388ac, content=Big help, big help. And surevlatipe news of course., beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=adeline, createdTime=Sun Sep 27 07:30:00 CST 2015, time=2015-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687516, encodeId=70db168e5163e, content=<a href='/topic/show?id=0ea224245e4' target=_blank style='color:#2F92EE;'>#亚太#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24245, encryptionId=0ea224245e4, topicName=亚太)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ef428388125, createdName=ms2536978994064944, createdTime=Mon Jul 12 19:47:00 CST 2010, time=2010-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=687, encodeId=fd3768e76, content=办的不错~, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=weiwei, createdTime=Wed Oct 14 15:27:00 CST 2009, time=2009-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543322, encodeId=5ad21543322d0, content=<a href='/topic/show?id=0dc224246b2' target=_blank style='color:#2F92EE;'>#亚太地区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24246, encryptionId=0dc224246b2, topicName=亚太地区)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=539b13566968, createdName=ms5439512287675881, createdTime=Wed Oct 14 04:47:00 CST 2009, time=2009-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605508, encodeId=33961605508d9, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Wed Oct 14 04:47:00 CST 2009, time=2009-10-14, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=37388, encodeId=f9843e388ac, content=Big help, big help. And surevlatipe news of course., beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=adeline, createdTime=Sun Sep 27 07:30:00 CST 2015, time=2015-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687516, encodeId=70db168e5163e, content=<a href='/topic/show?id=0ea224245e4' target=_blank style='color:#2F92EE;'>#亚太#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24245, encryptionId=0ea224245e4, topicName=亚太)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ef428388125, createdName=ms2536978994064944, createdTime=Mon Jul 12 19:47:00 CST 2010, time=2010-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=687, encodeId=fd3768e76, content=办的不错~, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=weiwei, createdTime=Wed Oct 14 15:27:00 CST 2009, time=2009-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543322, encodeId=5ad21543322d0, content=<a href='/topic/show?id=0dc224246b2' target=_blank style='color:#2F92EE;'>#亚太地区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24246, encryptionId=0dc224246b2, topicName=亚太地区)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=539b13566968, createdName=ms5439512287675881, createdTime=Wed Oct 14 04:47:00 CST 2009, time=2009-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605508, encodeId=33961605508d9, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Wed Oct 14 04:47:00 CST 2009, time=2009-10-14, status=1, ipAttribution=)]

相关资讯

SCI杂志的审稿周期和投稿难易程度如何判断?

当然首先我们需要了解审稿流程,可以参考:SCI杂志的审稿流程是什么样的? 这里比较详细说明了审稿流程,实际上审稿流程就等于审稿周期! 首先谈谈投稿难易程度,很多人似乎都一种误解,认为拒稿率高的杂志就肯定非常难投,投某个杂志的难易程度似乎就是由拒稿率决定的。 MedSci认为,文章只要能选择到合适的杂志,不管该杂志拒稿率有多高,对你来说都是很低的。比如大家都知道的Med hypothesis目前

2009年国庆中秋放假通知

尊敬的MedSci客户和会员们: 六十华诞,普天同庆! 根据国务院办公厅关于2009年国庆放假的相关规定,MedSci 2009年国庆放假安排如下: 10月1日至10月8日,假期共为8天,9月27日(星期日)、10月10日(&

SCI智能查询系统开通投稿经验分享

为了方便大家能够将成功地投稿经验分享出来,特在原有的智能查询系统 http://www.medsci.cn/sci 基础上,增加对杂志的投稿的建议,大家查询杂志名称后,在最后一栏中会有投稿建议,如果有其它网友分享建议后,您就能看到,对您选择该杂志提供有益的支持。如果您曾经投过哪些杂志,有哪些心得体会,也欢迎与其他朋友共享,共同增强中国的人发表SCI杂志的容易度。 让我们共同努力,我们将不定期根据

用审稿人的角度看SCI写作关键十大要点

本篇稿件是我们根据大量投稿文章,以及与许多杂志编辑交流的心得,并结合网站上相关的观点总结而成,供大家参考。 从审稿人的角度看,一片文章的命运往往在审稿人打开它的一瞬间就决定了。一个熟练的审稿人会在接到文章后用几分钟的时间通读一遍,从而对作者和文章的情况有一个初步的判断。在这里,审稿人最喜欢两个极端:一是通篇充满了细节上的

SCI杂志的审稿流程是什么样的? [机密]

有关SCI杂志书写,写作,投稿的流程,写得很多,但是审稿流程呢?很少有人知道。MedSci与一些杂志的主编沟通过,虽然各个杂志都不一样,但是有一些共通的地方。我们根据这些流程,然后根据实际情况进行相应的处理。 1 投稿。目前多是在线投稿,只有极少量杂志还是传统的方法。投稿分为几块,一是几家大公司旗下的杂志,如elsevier, spring, wiley,NPG等,它们都有标准的投稿系统,一般来

有关论文编辑中常见的专业问题

我们经常收到作者各种各样的“奇怪”问题,下面摘出一些有代表性的问题进行回复。 1 我是做中药单体的,怎么做才能发表SCI文章? MedSci回答:中药单体的文章是比较好发表的,但是关键在于特色。所谓特色,至少有以下三方面其中之一:1)采用一些新方法或新技术,或研究一些新的信号通路,新的基因等;2)研究很完善,系统;符合生物学和医学相关的论文研究,全面,而且也有一定的深度;3)符合标准药理学的研